Needleless IV Connectors May Be Causing Hospital Infections, FDA Warns

|

Federal regulators are warning that positive displacement needleless connectors used for intravenous access may increase the risk of hospital-acquired infections and death, leading to a request that manufacturers gather additional information on the potential problem. 

The FDA issued an initial communication on August 11, warning that several peer-reviewed clinical studies reported an increase in bloodstream infections once hospitals began using needle-free IV connectors that use positive displacement. The studies found that switching to other needleless connectors resulted in the infection rates dropping again. At least three deaths may be associated with positive displacement needleless connector bloodstream infections.

Positive displacement needleless connectors allow multiple IV sets and catheter hubs to deliver fluids and drugs into a patient without the risk of needle stick injuries to hospital staff or patients. They are also frequently referred to as luer activated valves or positive pressure systems.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

In a letter to infection control practitioners, the FDA also announced it will require nine companies to conduct postmarket surveillance studies on positive displacement connectors to see whether they are indeed associated with higher hospital infection rates.

The postmarket surveillance studies seek to answer two questions: What is the rate of bloodstream infections when that company’s specific positive displacement needleless connectors are used, and how does that rate compare to the rates of other needleless coneectors? And are there certain patient demographics, illnesses or uses that appear to have a stronger correlation with positive displacement needleless connector bloodstream infections than others?

The FDA hopes the information will allow the agency to make a more sound and fact-based recommendation on the use of the needleless systems.

Concern over the systems is nothing new. In October 2008, the Society for Healthcare Epidemiologists of America and the Infectious Disease Society of America recommended against the use of positive displacement needleless connectors unless there was first a thorough assessment of the risk and benefits. The recommendations were included in a report on useful strategies in preventing bloodstream hospital infections.


2 Comments


Bruce
I feel that the average citizen who knows about hospital acquired infections knows essentially NOTHING about the fact that the little piece of plastic that connects the IV to the catheter in their vein, is very likely to be the CAUSE of death or morbidity. It has been overlooked by everyone for 20 years as no one thought it was a problem until Rymed technologies proved it. The entire world should be advised about reducing their risk of blood stream infections and is may be as simple as saying I demand InVision Plus IV Connector to be used on me or my family member. How many more people need to die or be injured for months or years by BAD technology?

Bruce
It is not only positive displacement but negative displacement devices as well. The solution to this problem is ZERO fluid motion, that is Rymed’s Invision plus technology. NOT named in the FDA warning. Check out Rymedtech.com for the solution to this horrible problem that causes over 50,000 deaths in the US alone. This does not include the morbidity of catheter related blood stream infections. Costs for both exceed 5 billion dollars a year.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers.